The amino acid modifications in insulin glargine do not alter the pharmocological effect of the insulin, but alter the drug's pharmacokinetics/pharmacodynamics. Insulin glargine crystalises at physiological pH when injected subcutaneously. These crystals dissolve slowly and provide a more regular and longer-lasting release of insulin into the bloodstream compared to natural insulin.